The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / The Battle with Insurance Companies to Obtain Prescriptions

The Battle with Insurance Companies to Obtain Prescriptions

March 17, 2018 • By Philip Seo

  • Tweet
  • Email
Print-Friendly Version / Save PDF

The trouble is that Dr. Iinuma denied Mr. Washington’s appeal without having reviewed it. Mr. Washington sued Aetna for “reckless withholding of benefits,” and as part of the lawsuit, Dr. Iinuma was deposed. During the deposition, Dr. Iinuma admitted that he had never reviewed Mr. Washington’s records. He knew this because during his time as the medical director for Aetna, he had not reviewed any patient’s medical records. We apparently should not find this concerning, because he also admitted that he did not know anything about common variable immunodeficiency and did not know the consequences of stopping therapy.

You Might Also Like
  • Opinion: Insurance Companies Use Medically and Fiscally Irresponsible Formularies
  • PRACTICE PAGE: The ACR Takes on Insurance Companies
  • Two Years of Helping Patients Obtain Prescriptions
Explore This Issue
March 2018
Also By This Author
  • Enemy at the Gates: The Emerging Threat of COVID-19

Philip Seo, MD, MHSWith the system we have now, … [w]e learn to overdocument & undertreat, using regimens that we know are doomed to failure, because we must demonstrate that failure to gain access to the drugs that might actually help our patients.

The mind reels. We have all complained—privately and not so—about implacable insurance companies making arbitrary or ill-reasoned decisions, but I wonder how many of us suspected that these decisions were not reasoned at all. And yet, this seems like a natural extension of what we already knew to be true. Of all the times I have received a rejection of preapproval from an insurance company, I wonder how many times the undersigned recognized (or could even spell) granulomatosis with polyangiitis. Treating rheumatic diseases is challenging even for rheumatologists; it is difficult to imagine that every medical director of every insurance company is actually a peer.

Even if Dr. Iinuma had reviewed every page of Mr. Washington’s medical record, it seems doubtful that it would have changed his decision. That possibility was precluded by Dr. Iinuma’s lack of understanding of the patient’s illness and lack of interest in learning about the condition before rejecting a therapy that, by his own admission, he knew nothing about. Dr. Iinuma cannot be the first medical director to sign off on a decision that he was not qualified to make; he was just the first to be caught.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Aetna is now under investigation by California Insurance Commissioner Dave Jones, who told CNN, “If the health insurer is making decisions to deny coverage without a physician actually ever reviewing medical records, that’s of significant concern to me as insurance commissioner in California—and potentially a violation of law.”8

The Way Forward

Mr. Washington had the right idea. If a patient’s insurer makes a decision that seems to lack foundation, it may be time to call for an external referee. Instead of taking the insurance company to court, you may want to start by involving your state’s insurance commission. Truly egregious cases can be referred to your state’s attorney general. Either might help encourage the insurer to do the right thing. Longer term, however, we need more than better enforcement of existing laws; we need better laws.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Pages: 1 2 3 4 5 6 7 | Single Page

Filed Under: Legal, Legislation & Advocacy, Opinion, Pharma Co. News, Rheuminations Tagged With: drug benefits, pharmacy benefit managers, prescriptionIssue: March 2018

You Might Also Like:
  • Opinion: Insurance Companies Use Medically and Fiscally Irresponsible Formularies
  • PRACTICE PAGE: The ACR Takes on Insurance Companies
  • Two Years of Helping Patients Obtain Prescriptions
  • Are Insurance Companies’ Medication Directives Fiscally, Medically Questionable?

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)